Federal • US Congress
H.R. 1806: Triple-Negative Breast Cancer Research and Education Act of 2025
Rep. Joseph Morelle (D-NY)Referred
H.R. 1806 status: Referred.
1
What this bill does
Overall score
Score75/100 civic fit
RiskLow risk
ImpactHigh impact
Bill summary
No official summary is available for this bill yet.
Key analysis
Constitutionality100%
Bipartisan70%
Public opinion80%
2
Impact analysis
Environment
Mixed / Neutral
50%
Benefits
- No direct environmental benefit identified
Risks
- No direct environmental risk identified
Economy
Mixed / Neutral
50%
Benefits
- Potential for job creation in research and healthcare sectors.
Risks
- Authorization of appropriations may lead to increased government spending.
Society
Positive Outlook
85%
Benefits
- Increases research into triple-negative breast cancer.
- Improves public and healthcare provider education on the disease.
- Addresses disparities in breast cancer outcomes for minority women.
- Aims to improve early detection and survival rates.
Risks
- No direct social risk identified
3
How trustworthy & consequential it is
Confidence
highhigh
Information is complete and verified.
Analysis status
Full bill text (Congress.gov)
Source used for this bill's analysis.
Warning
The bill focuses on research and education, not direct patient treatment or access to care.
Limitation
The bill authorizes appropriations but does not specify exact funding amounts.
4
Where it stands
Introduced
Complete2
Committee
CurrentReferred
3
Floor
Upcoming4
Enacted
Upcoming5
How it affects your district
Set your location
Add your district to see how this bill may affect your community and who to contact.
6
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.